Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

135 results about "Diaminopyrimidine" patented technology

Diaminopyrimidines are a class of organic chemical compounds that include two amine groups on a pyrimidine ring. They include many dihydrofolate reductase inhibitor drugs (such as pyrimethamine, trimetrexate, and piritrexim and the antibiotics Iclaprim and trimethoprim).

Methods of using diaminopyrimidine P2X3 and P2X2/3 receptor modulators for treatment of respiratory and gastrointestinal diseases

Methods for treating respiratory and gastrointestinal diseases mediated by a P2X3 and / or a P2X2 / 3 receptor antagonist, the methods comprising administering to a subject in need thereof an effective amount of a compound of formula (I): or a pharmaceutically acceptable salt thereof, wherein D, X, Y, R1, R2, R3, R4, R5, R6, R7 and R8 are as defined herein.
Owner:ROCHE PALO ALTO LLC

Diaminopyrimidines as P2X3 and P2X2/3 modulators

Compounds and methods for treating diseases mediated by a P2X3 and / or a P2X2 / 3 receptor antagonist, the methods comprising administering to a subject in need thereof an effective amount of a compound of formula (I): wherein D, X, R1, R2, R3, R4, R5, R6, R7 and R8 are as defined herein.
Owner:ROCHE PALO ALTO LLC

Diaminopyrimidines as P2X3 and P2X2/3 antagonists

Compounds and methods for treating diseases mediated by a P2X3 and / or a P2X2 / 3 receptor antagonist, the methods comprising administering to a subject in need thereof an effective amount of a compound of formula (I): or a pharmaceutically acceptable salt, solvate or prodrug thereof, wherein D, X, Y, R1, R2, R3, R4, R5, R6, R7 and R8 are as defined herein.
Owner:ROCHE PALO ALTO LLC

Diaminopyrimidine derivatives as growth hormone secrectgogue receptor (GHS-R) antagonists

The present invention is related to compounds of formula (I), or a therapeutically suitable salt or prodrug thereof, the preparation of the compounds, compositions containing the compounds and the use of the compounds in the prevention or treatment of disorders regulated by the action of ghrelin receptor, including Prader-Willi syndrome, eating disorder, weight gain, weight-loss maintainance following diet and exercise, obesity, and disorders associated with obesity such as noninsulin dependent diabetes mellitus.
Owner:KOSOGOF CHRISTI +9

Process for preparing 4,6-diaminopyrimido[5,4-d]pyrimidines

A process for preparing 4,6-diaminopyrimido[5,4-d]pyrimidines of formula I, wherein R1 denotes a hydrogen atom or a C1-C6 alkyl group, R2 denotes an optionally substituted C6-C10 aryl group, R3 denotes a hydrogen atom or a C1-C6 alkyl group, and R4 denotes a hydrogen atom or an optionally substituted C1-C6 alkyl, C3-C6 alkenyl, C3-C8cycloalkyl or a 4- to 7-membered, nitrogen-containing heterocyclyl group, or R3 and R4 together with the nitrogen atom linked to them denote an optionally substituted heterocyclyl group.
Owner:BOEHRINGER INGELHEIM PHARM KG

Amiopyrimidine-modified gold nano particles and preparation method and use thereof

The invention provides series amiopyrimidine-modified gold nano particles. In the amiopyrimidine-modified gold nano particles, the amiopyrimidine may be one or more of 2-thiol-4,6-diamino-pyrimidine, 2-thiol-4-amino-pyrimidine and 2,4-diamino-6-mercaptopyrimidine. The particle size of the amiopyrimidine-modified gold nano particles is 1.5 to 10.0 nanometers; and the molar content ratio of amiopyrimidine molecules to gold element in the nano particles ranges from 0.1 to 0.9. The amiopyrimidine-modified gold nano particles have antibacterial effect, can be widely used for preparing antibacterial medicines such as anti-gram-negative bacilli penicillins medicines, anti-gram-positive bacterium medicines or / and anti-multi-medicine-resistance clinically isolated bacterium medicines. The invention also provides the preparation method and use of the amiopyrimidine-modified gold nano particles. The invention further provides antibacterial medicines containing the amiopyrimidine-modified gold nano particles.
Owner:重庆龙翼生物科技有限公司

Diaminopyrimidine compound and composition containing same

The invention provides a diaminopyrimidine compound and a composition containing the same and discloses the diaminopyrimidine compound shown as in a formula (I) and a drug combination containing the compound or salt thereof acceptable in crystal form and pharmacy, hydrate or solvent complex, stereoisomer, pro-drug or isotope variant. The diaminopyrimidine compound and the composition containing the same have excellent inhibition effect on protein kinase and have better pharmacokinetic parameter characteristics, and drug concentration of the compound in animal bodies can be increased to improve drug efficacy and safety.
Owner:SHENZHEN TARGETRX INC

2,4-diamino-pyrimidine compounds and method for making and using the compounds

Compounds within the scope of the present invention have a Formula 1or a salt or prodrug thereof, where ring A is selected from cycloaliphatic; ring B is aryl; R1 is selected from (C1-C10)alkyl, (C3-C10)cycloalkyl, halo, aryl, and heteroaryl; and R2 and R3 are independently selected from hydrogen and (C1-C6)alkyl. Disclosed compounds may have an IRAK4 IC50 of from 0.003 μM to 3.7 μM; a TAK1 IC50 of from 0.008 μM to 132 μM; and / or an IRAK4 / TAK1 selectivity of from 1 to 450. Particular compounds may have an IRAK4 / TAK1 selectivity of from 100 to 500. Disclosed compositions may be formulated as pharmaceutical compositions. A method for using the compounds and / or compositions also are disclosed. The method may comprise administering to a subject an effective amount of a compound within the scope of the present invention, particularly to selectively inhibit IRAK 1 and / or IRAK4 over TAK1.
Owner:RIGEL PHARMA

Hair-growing composition and application thereof

The invention discloses a hair-growing composition and application thereof. The hair-growing composition is mainly prepared from the following components in parts by mass: 0.1 to 5 parts of pyrrolidyldiaminopyrimidine oxide and 0.1 to 5 parts of dimethyl sulfone, wherein the pyrrolidyl diaminopyrimidine oxide can promote the telophase in the hair life cycle to be changed into anagen; the dimethylsulfone provides an organic sulfur nutrient source as a necessary condition for the synthesis of keratin fibers and also can remove free radicals and inhibit inflammation; by combined use of the twosubstances, multiple effects of promoting blood circulation, opening potassium channels, and promoting the proliferation of hair follicle cells and the expression of human keratin fibers can be realized; a good hair growth effect is achieved from inside to outside.
Owner:广州汀兰生物科技有限公司

Production method of diaminopyrimidine compounds

The present invention relates to a novel production method of a diaminopyrimidine compound useful as an intermediate for various compounds having a pharmacological activity, a novel intermediate useful for producing said compound, and a production method of the intermediate.The present invention provides a novel 5-aminopyrimidine compound represented by the following formula (2) and a novel 4,5-diaminopyrimidine compound represented by the formula (3), as well as production methods of the compounds of the following formulas (2) to (6).wherein each symbol is as defined in the specification.
Owner:AJINOMOTO CO INC

Substituted diaminopyrimidine compound, composition comprising compound and application of compound

The invention provides substituted diaminopyrimidine compound, a composition comprising the compound and application of the compound. The substituted diaminopyrimidine compound is diaminopyrimidine compound shown as in formula (I) or its crystal-form pharmaceutically acceptable salts and prodrugs, and stereoisomer, hydrate or solvent compound. The substituted diaminopyrimidine compound disclosed herein and the composition comprising the compound have excellent inhibitory action on EGFR (epidermal growth factor receptor) kinase, have better pharmacokinetics parameter characteristics, and can increase the drug concentration of the compound in an animal body to provide improved drug therapeutic effect and safety.
Owner:SHENZHEN TARGETRX INC

Substituted diaminopyrimidine compound and application thereof in preparation of antineoplastic drugs

The invention provides a substituted diaminopyrimidine compound and medicinal salt thereof. The structure of the substituted diaminopyrimidine compound is as shown in a general formula (I). A pharmacodynamic test proves that the compound is capable of effectively inhibiting growth of multiple tumor cells and can be used for preparing anti-tumor drugs, and meanwhile, the drug resistance of EGFR T790M can be overcome.
Owner:药谷(温州)科技发展有限公司

Pyrimidopyrimidine compound, nucleoside analog derivative thereof, preparation method thereof and use thereof

The invention relates to a pyrimidopyrimidine compound and a nucleoside analog derivative thereof. The pyrimidopyrimidine compound and the nucleoside analog derivative thereof prepared in the invention have certain hepatitis virus inhibition activities, and 4,7-diamino-1-(beta-2-deoxy-D-ribofuranose)pyrimido[4,5-d]pyrimidine-2,5(1H,6H)-dione and 4,7-diaminopyrimido[4,5-d]pyrimidine-2,5(1H,6H)-dione perform obvious virus copying inhibition potentials and are better than ribavirin, so a new selection is provided for clinical medicines.
Owner:WEST CHINA HOSPITAL SICHUAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products